Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Loperamide hydrochloride and simeticone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Loperamide 2mg / Simeticone 125mg tablets
0104020P0AAAAAA
|
Loperamide hydrochloride/simeticone | Loperamide hydrochloride and simeticone | Gastro-Intestinal System | 442 |
|
Imodium Dual Action Relief tablets
0104020P0BBACAA
|
Imodium Plus | Loperamide hydrochloride and simeticone | Gastro-Intestinal System | 302 |
|
Imodium Plus caplets
0104020P0BBAAAA
|
Imodium Plus | Loperamide hydrochloride and simeticone | Gastro-Intestinal System | 157 |
|
Imodium Plus chewable tablets
0104020P0BBABAB
|
Imodium Plus | Loperamide hydrochloride and simeticone | Gastro-Intestinal System | No data available |
|
Simeticone 125mg / Loperamide 2mg chewable tablets
0104020P0AAABAB
|
Loperamide hydrochloride/simeticone | Loperamide hydrochloride and simeticone | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.